In order to address growing complexity and successfully develop new solutions, stakeholders in biomedical research need each other – and each other’s proprietary resources.
An organization’s success depends on resources such as compounds, data, imaging/diagnostic technologies, or scientific expertise. However, making the most of these resources means having the vision to move beyond simply protecting them, and instead to start exploring their wider potential.
Working together with suitable partners at the early stages of technology development or drug discovery can yield results that surpass what any individual organization could achieve on its own. This is one of the most important ways in which organizations can take their own work and achievements to the next level.
Lygature helps to facilitate and safeguard the flow of competitive information between partners. Proven capabilities as an independent intermediary mean that resources can be effectively and safely shared, and more ambitious programs completed.
Public-private research based on unique collaboration between a total of 96 partners.
Goal: Collaborative pharmaceutical research addressing WHO Priority Medicines agenda.